CVS Beats EPS Estimates, Losses Loom
CVS Health reported mixed fourth-quarter earnings, beating estimates but showing challenges in key areas.
CVS Health (NYSE:CVS), a leading integrated healthcare and pharmacy solutions provider, released its fourth-quarter 2024 earnings on February 12, 2025.
The earnings surpassed analyst expectations with an adjusted earnings per share (EPS) of $1.19, beating estimates of $0.91 by 30.8%. Total revenue reached $97.7 billion, exceeding the $97.1 billion forecast and marking a year-over-year increase of 4.2%.
Despite these achievements, the quarter posed challenges, particularly in the Health Care Benefits segment, indicating mixed performance overall.
